Search research articles
Contact Us
Filters
Showing results (51-60 of 58) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 58 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 30, 2012
Sex moderates circadian chemotherapy effects on survival of patients with metastatic colorectal cancer: a meta-analysis
S Giacchetti, P A Dugué, P F Innominato, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 10, 2011
Phase II study of panitumumab, oxaliplatin, 5-fluorouracil, and concurrent radiotherapy as preoperative treatment in high-risk locally advanced rectal cancer patients (StarPan/STAR-02 Study)
C Pinto, F Di Fabio, E Maiello, et al.
Breast Cancer Research and Treatment
|
June 1, 2000
Weekly schedule of vinorelbine in pretreated breast cancer patients
C Nisticò, C Garufi, M Milella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 8, 2012
Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?
D Santini, B Vincenzi, R Addeo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2017
Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?
D Santini, B Vincenzi, R Addeo, et al.
ESMO Open
|
January 28, 2025
Atezolizumab plus bevacizumab as first-line treatment of unresectable hepatocellular carcinoma: interim analysis results from the phase IIIb AMETHISTA trial
F Piscaglia, G Masi, E Martinelli, et al.
In Vivo (Athens, Greece)
|
January 6, 2007
A multicentric phase II clinical trial on intra-arterial hepatic radiotherapy with 90yttrium SIR-spheres in unresectable, colorectal liver metastases refractory to i.v. chemotherapy: preliminary results on toxicity and response rates
R Mancini, L Carpanese, R Sciuto, et al.
ESMO Open
|
October 29, 2025
Genomic profiling of high tumor mutational load in microsatellite-stable colorectal cancer uncovers MAPK signaling pathway alterations following anti-EGFR therapy
L Boscolo Bielo, S Napolitano, A Avallone, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 58) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 58 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 30, 2012
Sex moderates circadian chemotherapy effects on survival of patients with metastatic colorectal cancer: a meta-analysis
S Giacchetti, P A Dugué, P F Innominato, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 10, 2011
Phase II study of panitumumab, oxaliplatin, 5-fluorouracil, and concurrent radiotherapy as preoperative treatment in high-risk locally advanced rectal cancer patients (StarPan/STAR-02 Study)
C Pinto, F Di Fabio, E Maiello, et al.
Breast Cancer Research and Treatment
|
June 1, 2000
Weekly schedule of vinorelbine in pretreated breast cancer patients
C Nisticò, C Garufi, M Milella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 8, 2012
Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?
D Santini, B Vincenzi, R Addeo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2017
Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?
D Santini, B Vincenzi, R Addeo, et al.
ESMO Open
|
January 28, 2025
Atezolizumab plus bevacizumab as first-line treatment of unresectable hepatocellular carcinoma: interim analysis results from the phase IIIb AMETHISTA trial
F Piscaglia, G Masi, E Martinelli, et al.
In Vivo (Athens, Greece)
|
January 6, 2007
A multicentric phase II clinical trial on intra-arterial hepatic radiotherapy with 90yttrium SIR-spheres in unresectable, colorectal liver metastases refractory to i.v. chemotherapy: preliminary results on toxicity and response rates
R Mancini, L Carpanese, R Sciuto, et al.
ESMO Open
|
October 29, 2025
Genomic profiling of high tumor mutational load in microsatellite-stable colorectal cancer uncovers MAPK signaling pathway alterations following anti-EGFR therapy
L Boscolo Bielo, S Napolitano, A Avallone, et al.
Page
of 6